> ## Content Index
> Fetch the complete content index at: https://adjacent.media/llms.txt
> Use this file to discover other available public pages before exploring further.

# Eli Lilly bets $2.75 billion on AI-discovered drugs
- URL: https://adjacent.media/signals/eli-lilly-bets-2-75-billion-on-ai-discovered-drugs/
- Published: 2026-03-30T10:15:27.000Z
- Updated: 2026-04-02T09:56:23.000Z
- Description: Semafor // Big Pharma’s largest commitment to AI-native drug discovery signals that generative AI has crossed from experimental lab tool to business-critical infrastructure in pharmaceutical R&D.
- Author: Jonathan Greene
- Tags: #signal, theme-ai, drug discovery

Source: [Semafor](https://www.semafor.com/article/03/29/2026/eli-lilly-leans-into-ai-drug-discovery?ref=adjacent.media)

Big Pharma’s largest commitment to AI-native drug discovery signals that generative AI has crossed from experimental lab tool to business-critical infrastructure in pharmaceutical R&D. The deal with Insilico Medicine—a company that has already moved 28 AI-designed candidates into development—suggests the bottleneck in drug discovery is shifting from scientific feasibility to manufacturing, regulatory approval, and clinical validation. This represents a structural shift in how pharmaceutical value gets created: companies that can integrate AI pipelines at scale may compress drug development timelines by years, fundamentally reshaping competitive advantage in an industry built on patent exclusivity windows.